Table 1.

Characteristics of the studies.

References	Year	Study Design	Type of Participants	Mean/Median Age	Sample Size	n, Male	n, Female	Osteoporosis Diagnostic Criteria	Sarcopenia Diagnostic Criteria	n, Osteosarcopenic Subjects	%, Osteosarcopenic Subjects
[19]	2015	transversal	fragility, falls, fractures	NA	679	224	455	WHO	* p < 0.05	258	38%
[20]	2015	observational	hip fracture	82	239	72	167	WHO	AWGS	166	69%
[21]	2016	control cases	hip fracture	NA	359	87	272	WHO	AWGS	NA	NA
[22]	2016	prospective-observational	community living seniors	70.5	750	0	750	WHO	ALM < −DS	NA	NA
[23]	2016	observational	community living seniors	NA	68	21	47	WHO	EWGSOP	19	28%
[24]	2018	retrospective	hip fracture	77.8	324	78	246	WHO	AWGS	93	29%
[25]	2018	transversal	consecutively admitted to hospital, first hip fracture	81.4	80	80	0	WHO	* p < 0.05	NA	NA
[26]	2018	longitudinal	community living seniors	76.7	1575	1575	0	WHO	EWGSOP	131	8%
[27]	2019	transversal	hospitalised	80.6	141	57	84	WHO	EWGSOP	20	14%
[28]	2019	prospective-observational	community living seniors	78.8	106	34	72	WHO	* p < 0.05	NA	NA
[29]	2019	transversal	fragility, falls, fractures	77.9	253	57	196	WHO	EWGSOP2	138	55%
[30]	2019	prospective-transversal	postmenopausal subjects	64.14	140	0	140	WHO	EWGSOP	90	64%
[31]	2019	transversal	community living seniors	76	484	147	337	WHO	EWGSOP2	25	5%
[32]	2019	transversal	healthy subjects	71.4	427	205	222	* p < 0.05	* p < 0.05	36	8%
[13]	2020	transversal	community living healthy seniors	75	529	232	297	WHO	EWGSOP2	8	2%
[33]	2020	transversal	hip fracture	79.7	350	0	350	WHO	EWGSOP2	NA	NA